Navigation Links
GenoSpace Founder and CEO Receives "Champions of Change" Award from White House

CAMBRIDGE, Mass., June 20, 2013 /PRNewswire/ -- The White House today recognized John Quackenbush, PhD, founder and Chief Executive Officer of GenoSpace, LLC, as an Open Science "Champion of Change". The program recognizes outstanding individuals, organizations and research projects promoting and using open scientific data and publications to accelerate progress and improve our world. GenoSpace builds information systems capable of storing and integrating genomic information and health data for clinical care and advanced research.  Kathy Giusti, founder and Chief Executive Officer of the Multiple Myeloma Research Foundation (MMRF), was also honored as an Open Science "Champion of Change".

(Logo: )

In 2011, the Multiple Myeloma Research Foundation (MMRF) launched the $40 million CoMMpass study, an open-science initiative that unites competitors from the pharmaceutical and biotech industries, academic institutions, and community cancer centers. The MMRF CoMMpass study will follow 1,000 patients for five years, monitoring their response to treatment and sequencing their cancer genomes to understand how they evolve under the selective pressure of drugs with which they are being treated. CoMMpass will provide unprecedented data that will be freely shared without restriction with anyone interested in using it to search for a cure.

In 2012, the MMRF turned to GenoSpace to solve the problem of making the data emerging from CoMMpass available, accessible, and useful to research community. GenoSpace for Research™, which enables the MMRF Researcher Gateway, is a revolutionary software system that integrates complex data and provides collaborating scientists with advanced analytical and visualization tools that drive discovery. The MMRF Researcher Gateway is currently open to the pharmaceutical sponsors of CoMMpass, and will be made available to the public in September of this year.

"We are very proud to have partnered with the MMRF and to be honored with them by the White House," said Quackenbush. "This award recognizes the groundbreaking work the team at GenoSpace has done in creating tools to support the next generation of genomic research and personalized medicine."

About GenoSpace
At GenoSpace, we are Digital Architects of Genomic Medicine™. GenoSpace is a Cambridge, Massachusetts-based company that has developed robust software systems for securely storing vast amounts of genomic and health data, and providing it in formats specific to its diverse user communities. GenoSpace for Clinical Care facilitates clinically actionable interpretation and report generation for precision medicine. GenoSpace for Research provides dynamic analysis, visualization and collaboration tools. GenoSpace for Patient Communities enables patient-centric exploration and advancement of personalized medicine. Please visit for more information.

GenoSpace Contact:
John Quackenbush
GenoSpace, LLC
700 Massachusetts Ave
Cambridge MA 02139
Phone: 617-520-4182

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GenoSpace Expands Its Management Team by Appointing Daniel Meyer as Chief Financial Officer
2. GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem" for Advancing 21st-Century Personalized Medicine
3. Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013
4. Future of Pre- and Probiotics to be Discussed by Kibow Biotech Founder During SupplySide MarketPlace 2013 Global Expo & Conference
5. TREVENTIS Corporation Scientific Founder, Donald Weaver, MD, Named Sobey Chair in Alzheimers Disease Research, His Third Endowed Chair
6. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
7. Radiotherapy Clinics of Georgias Founder Returns Home to Celebrate Cancer Survivors and Receive Lifetime Achievement Award
8. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
9. Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval
10. AMRI Burlington Receives DEA Approval to Handle Controlled Substances
11. zuChem Receives Two Polyol Patents
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division ... tuned and optimized exclusively for Okuma CNC machining centers at The International Manufacturing ... collaboration among several companies with expertise in toolholding, cutting tools, machining dynamics and ...
Breaking Biology Technology:
(Date:5/20/2016)... 20, 2016  VoiceIt is excited to announce ... By working together, VoiceIt and VoicePass ... and VoicePass take slightly different approaches to voice ... security and usability. ... new partnership. "This marketing and technology ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):